For Nephrology Fellows

AASK

• Agodoa et al. Effect of Ramipril vs Amlodipine...JAMA 2001.pdf
• Fogo et al. Accuracy of the diagnosis of hypertensive nephrosclerosis in...KI 1997.pdf
• Lea et al. The relationship between magnitude...Arch Intern Med 2005.pdf
• Wright et al. Effect of blood pressure lowering and antihypertensive class...JAMA 2002.pdf
• Wright et al. Success blood pressure control...Arch Intern Med 2002.pdf

ABCD

• Estacio & Schrier. Antihypertensive therapy in type 2 diabetes...Am J Cardiol 1998.pdf
• Estacio et al. The Effect of Nisoldipine as compared with Enalapril...NEJM 1998.pdf
• Schrier et al. Effect of aggressive blood pressure control...KI 2002.pdf

AIPRD

• Jafar et al. Proteinuria as a modifiable risk factor...KI 2001.pdf

ALLHAT

• ALLHAT Collaborative Research Group. Major outcomes in high-risk...JAMA 2002.pdf
• ALLHAT Collaborative Research Group. Major outcomes in moderately....JAMA 2002.pdf
• Furberg et al. Clinical implications of recent findings from ALLHAT. Ann Intern Med 2001.pdf
• Rahman et al. Renal outcomes in high-risk hypertensive pts...Arch Intern Med 2005.pdf
• Wright et al. Outcomes in hypertensive black and nonblack patients...JAMA 2005.pdf

CALM

• Mogensen et al. Randomised controlled trial of dual blockade of renin...BMJ 2000.pdf

CAPPP

• Hansson et al. Effect ACE inhibition compared with conventional therapy...Lancet 1999.pdf
• Niskanen et al. Reduced cardiovascular morbidity and mortality in...Diabetes Care 2001.pdf

COOPERATE

• Nakao et al. Combination treatment of ARB and ACE in non-dabetic...Lancet 2003.pdf

Diabetic Nephropathy

• Hall, PM. Prevention of progression in diabetic nephropathy. Diabetes Spectr 2006.pdf
• Lewis et al. Renoprotective effect of irbesartan in type 2 DM. NEJM 2001.pdf
• Parving et al. The effect of irbesartan on the development of DN in...NEJM 2001.pdf
• Rachmani et al. Teaching pts to monitor their risk factors retards the...Diabet Med 2002.pdf
• Remuzzi et al. Nephropathy in pts with type 2 DM. NEJM 2002.pdf
• Rossing et al. Dual blockade of RAS in diabetic nephropathy. Diabetes Care 2002.pdf

FACET

• Tatti et al. Outcomes of the Fosinopril vs Amlodipine...Diabetes Care 1998.pdf

HOPE

• Gerstein et al. Albuminuria and risk of cardiovascular events, death, and...JAMA 2001.pdf
• HOPE Study Investigators. Effects of ramipril on cardiovascular and...Lancet 2000.pdf
• HOPE Study Investigators. Effects of ramipril on cardiovascular events in...NEJM 2000.pdf
• Johannes et al. Renal insufficiency as a predictor of cardio...Ann Intern Med 2001.pdf
• Malcolm et al. Prevention of heart failure in in pts in the HOPE study...Circulation 2003.pdf

INSIGHT

• Brown et al. Morbidity and mortality in pts randomized to long acting CCB...Lancet 2000.pdf

LIFE

• Dahlof et al. Cardiovascular morbidity and mortality in the Losartan...Lancet 2002.pdf
• Kjeldsen et al. Effects of losartan on cardiovascular morbidity and mortality...JAMA 2002.pdf
• Kjeldsen et al. Lowering of blood pressure and predictors of...Am J Hypertens 2000.pdf
• Lindholm et al. Cardiovascular morbidity and mortality in pts with....Lancet 2002.pdf

MARVAL

• Viberti et al. Microalbumin reduction with valsartan in pts with DM2...Circulation 2002.pdf

MDRD

• Peterson et al. Blood pressure control, proteinuria, and the progression of renal disease...Ann Intern Med 1995.mht
• Sarnak et al. The effect of a lower target bp...Ann Intern Med 2005.pdf

MRFIT

• Brancati et al. Risk of ESRD in DM...JAMA 1997.html
• Klag et al. ESRD in african-american and white men...JAMA 1997.html

NORDIL

• Hansson et al. Randomised trial of effects of calcium antagonists...Lancet 2000.pdf

Pancreas Transplant

• Fioretto et al. Reversal of lesions of diabetic nephropathy after pancreas...NEJM 1998.pdf

RENAAL

• Bakris et al. Effects of blood pressure level on progression of diabetic nephropathy. Arch Intern Med 2003.pdf
• Brenner et al. Effects of losartan on renal and cardiovascular outcomes in...NEJM 2001.pdf
• de Zeeuw et al. Proteinuria, a target for renoprotection in pts with type 2...KI 2004.pdf
• de Zeeuw et al. Renal risk and renoprotection among ethnic groups...KI 2006.pdf
• Eijelkamp et al. Albuminuria is a target for renoprotective therapy...JASN 2007.pdf
• Keane et al. The risk of developing ESRD in pts with type 2 diabetes and...KI 2003.pdf
• Shahinfar et al. Baseline predictors of ESRD risk in pts with type 2 diabetes...KI 2005.pdf
• Shahinfar et al. Losartan in pts with type 2 diabetes and proteinuria...KI 2002.pdf
• Thomas et al. Dialysis delayed is death prevented...KI 2003.pdf
• Zhang et al. Importance of baseline distribution or proteinuria...JASN 2005.pdf

SHEP

• Curb et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk...JAMA 1996.html

STOP-Hypertension

• Lindholm et al. Comparison of antihypertensive treatments in...J Hypertens 2000.pdf

SYS-EUR

• Tuomilehto et al. Effects of calcium-channel blockade in older pts with DM...NEJM 1999.pdf

UKPDS

• Adler et al. Assoc of systolic blood pressure with macrovascular and...BMJ 2000.pdf
• Stratton et al. Assoc of glycaemia with macrovascular and microvascular...BMJ 2000.pdf
• UK Prospective Diabetes Study Group. Cost effectiveness analysis of...BMJ 1998.pdf
• UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in...BMJ 1998.pdf
• UK Prospective Diabetes Study Group. Tight blood pressure control and...BMJ 1998.pdf

Fluid/Electrolytes

• Adrogue & Madias. Hypernatremia. NEJM 2000.pdf
• Adrogue & Madias. Hyponatremia. NEJM 2000..pdf
• Scheinman et al. Genetic disorders of renal electrolyte transport. NEJM 1999..pdf
• Thaler et al. Beer potomania in non-beer drinkers. Effect of low dietary solute intake. AJKD 1998.pdf

Miscellaneous

• Maschio et al. Effecct of benazepril on progression of CKD. NEJM 1996.pdf
• Mehran et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardio 2004.pdf
• Perneger et al. History of hypertension in pts treated for ESRD. J Hypertens 1997.pdf
• Femoral Vs IJ Hemodialysis cathetr and bacteremia JAMA. 2008;299(20):2413-2422

Dialysis

• Canusa Study (J, Am. Soc. Nephrol. 1996; 7:198-207)
• Lower Probability of Patient Survival with Continuous Peritoneal Dialysis in the United States Compared with Canada ( J Am Soc Nephrol. 1997 Jun;8(6):965-71)
• Reanalysis of Canusa ( J Am Soc Nephrol 12: 2158–2162, 2001)
• HEMO Study (N Engl J Med 2002;347:2010-9.)
• Serum Beta-2 Microglobulin Levels Predict Mortality in Dialysis Patients: Results of the HEMO Study (J Am Soc Nephrol. 2006 Feb;17(2):546-55)
• ADEMEX Study (J Am Soc Nephrol 13: 1307–1320, 2002)
• The European APD Outcome Study (J Am Soc Nephrol 14: 2948–2957, 2003)
• Daily Hemodialysis and the Outcome of ARF (N Engl J Med 2002;346:305-10.)
• CRRT in critically ill. Review article (Kidney international 2005; 67:781-795)
• A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure (Kidney International, Vol. 60 (2001), pp. 1154–1163)
• Continuous venovenous haemodiafi ltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre
  randomised trial (Lancet 2006; 368: 379–85
• Intensity of Renal Support in critically ill Patients with AKI. NEJM July 2008